1. Home
  2. Age-related Macular Degeneration

Age-related Macular Degeneration

RetinaCME ® Presents Updates from Vancouver: Best of Ophthalmology Research on Improving Outcomes With New Treatment Options for Neovascular Retinal Diseases

RetinaCME® Presents Updates from Vancouver: Best of Ophthalmology Research on Improving Outcomes With New Treatment Options for Neovascular Retinal Diseases

The integration of intravitreal anti-vascular endothelial growth factor (a…

Expiration Date: 5/8/2020

Max Credits: 0

View Activity

Rapid Response from Vienna 2018: Seeking the Right Dose of Anti-VEGF Therapy for Age-related Macular Degeneration and Diabetic Retinopathy

Rapid Response from Vienna 2018: Seeking the Right Dose of Anti-VEGF Therapy for Age-related Macular Degeneration and Diabetic Retinopathy

The integration of anti-vascular endothelial growth factor (VEGF) intravit…

Expiration Date: 9/27/2019

Max Credits: 0

View Activity

RetinaCME Presents Updates from Honolulu: Best of Ophthalmology Research - Long-term Management of AMD

RetinaCME Presents Updates from Honolulu: Best of Ophthalmology Research - Long-term Management of AMD

Age-related macular degeneration (AMD) is a leading cause of irreversible …

Expiration Date: 5/14/2019

Max Credits: 0

View Activity

RetinaCME Presents Updates from Honolulu: Best of Ophthalmology Research – Modulation of Angiopoietin/Tie2 System for the Treatment of Neovascular Retinal Disease

RetinaCME Presents Updates from Honolulu: Best of Ophthalmology Research – Modulation of Angiopoietin/Tie2 System for the Treatment of Neovascular Retinal Disease

Intravitreal anti-vascular endothelial growth factor (VEGF) therapy has re…

Expiration Date: 5/10/2019

Max Credits: 0

View Activity

Rapid Response from Barcelona 2017: State-of-the-Science Updates on the Medical Management of Retinal Vascular Diseases

Rapid Response from Barcelona 2017: State-of-the-Science Updates on the Medical Management of Retinal Vascular Diseases

Diagnostic and therapeutic algorithms for the management of retinal vascul…

Expiration Date: 9/18/2018

Max Credits: 0

View Activity

Rapid Response from Hawaii: Improving Intravitreal Therapy for Retinal Disease

Rapid Response from Hawaii: Improving Intravitreal Therapy for Retinal Disease

The integration of anti-VEGF therapy into front-line treatment strategies …

Expiration Date: 1/29/2019

Max Credits: 0

View Activity

Newly Approved and Emerging Approaches that Improve the Delivery of Anti-VEGF Medication in nAMD

Newly Approved and Emerging Approaches that Improve the Delivery of Anti-VEGF Medication in nAMD

Pinnacle clinical trials evaluating anti–vascular endothelial growth facto…

Expiration Date: 7/22/2021

Max Credits: 0.25

View Activity

Current Undertreatment of Patients With nAMD – Defining the Need for More Flexible Dosing

Current Undertreatment of Patients With nAMD – Defining the Need for More Flexible Dosing

Pinnacle clinical trials evaluating anti–vascular endothelial growth facto…

Expiration Date: 7/22/2021

Max Credits: 0.25

View Activity

Persistent Retinal Fluid Post-treatment and its Effect on Visual Outcomes in Patients With nAMD

Persistent Retinal Fluid Post-treatment and its Effect on Visual Outcomes in Patients With nAMD

Pinnacle clinical trials evaluating anti–vascular endothelial growth facto…

Expiration Date: 7/22/2021

Max Credits: 0.25

View Activity

Using Current Anti-VEGF Agents to Lessen the Injection Burden and Improve Adherence and Visual Outcomes

Using Current Anti-VEGF Agents to Lessen the Injection Burden and Improve Adherence and Visual Outcomes

Pinnacle clinical trials evaluating anti–vascular endothelial growth facto…

Expiration Date: 7/22/2021

Max Credits: 0.25

View Activity